Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).

No abstract is available for this paper.

• Publication year

  2006

• Venue

  Blood

• Publication date

  2006-11-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2007-09-113647PMID 18202226PMCID PMC2265458
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Randomized phase III trial of fludarabine plus cyclophosphamide with or without oblimersen sodium (Bcl-2 antisense) in patients with relapsed or refractory chronic lymphocytic leukemia.

  2007cited by this paper
• Comparison of pharmacokinetic and metabolic profiling among gossypol, apogossypol and apogossypol hexaacetate

  2007cited by this paper
• Mechanisms of apoptosis sensitivity and resistance to the BH3 mimetic ABT-737 in acute myeloid leukemia.

  2006cited by this paper
• MicroRNAs and chromosomal abnormalities in cancer cells

  2006cited by this paper
• Comparison of chemical inhibitors of antiapoptotic Bcl-2-family proteins

  2006cited by this paper
• MicroRNA signatures in human cancers

  2006cited by this paper
• Antitumor activity of JS-K [O2-(2,4-dinitrophenyl) 1-[(4-ethoxycarbonyl)piperazin-1-yl]diazen-1-ium-1,2-diolate] and related O2-aryl diazeniumdiolates in vitro and in vivo.

  2006cited by this paper
• CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension.

  2006cited by this paper
• Quantitative determination of apogossypol, a pro-apoptotic analog of gossypol, in mouse plasma using LC/MS/MS.

  2006cited by this paper
• miR-15 and miR-16 induce apoptosis by targeting BCL2.

  2005cited by this paper
• Small-molecule antagonists of apoptosis suppressor XIAP exhibit broad antitumor activity.

  2004cited by this paper
• TNF receptor-associated factor (TRAF) domain and Bcl-2 cooperate to induce small B cell lymphoma/chronic lymphocytic leukemia in transgenic mice.

  2004cited by this paper
• Rational Design and Real Time, In-Cell Detection of the Proapoptotic Activity of a Novel Compound Targeting Bcl-XL

  2004cited by this paper
• Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).

  2004cited by this paper
• The Bcl-2 family: roles in cell survival and oncogenesis

  2003cited by this paper
• Development of an immunoassay for diagnosis of exposure to toxic organophosphorus compounds

  2001cited by this paper
• TNFR-Associated Factor Family Protein Expression in Normal Tissues and Lymphoid Malignancies

  2000cited by this paper
• The prognostic impact of BCL2 protein expression in acute myelogenous leukemia varies with cytogenetics.

  1999cited by this paper
• NF-kappaB-mediated up-regulation of Bcl-x and Bfl-1/A1 is required for CD40 survival signaling in B lymphocytes.

  1999cited by this paper
• Enhanced Oxidative Stress and Altered Antioxidants in Brains of Bcl‐2‐Deficient Mice

  1998cited by this paper
• Bcl-2 family proteins and the regulation of programmed cell death in leukemia and lymphoma.

  1996cited by this paper
• Bcl-2 family proteins: regulators of chemoresistance in cancer.

  1995cited by this paper
• The immunological profile of B-cell disorders and proposal of a scoring system for the diagnosis of CLL.

  1994cited by this paper
• Regulation of chemoresistance by the bcl-2 oncoprotein in non-Hodgkin's lymphoma and lymphocytic leukemia cell lines.

  1994cited by this paper
• High expression of bcl-2 protein in acute myeloid leukemia cells is associated with poor response to chemotherapy.

  1993cited by this paper
• Involvement of BCL-2 in glucocorticoid-induced apoptosis of human pre-B-leukemias.

  1992cited by this paper
• Differential effects of Bcl-2 on T and B cells in transgenic mice.

  1992cited by this paper
• Antisense-mediated inhibition of BCL2 protooncogene expression and leukemic cell growth and survival: comparisons of phosphodiester and phosphorothioate oligodeoxynucleotides.

  1990cited by this paper
• Immunophenotypic diagnosis of clinical and preclinical chronic lymphatic leukemia by using monoclonal antibodies against the cCLLa, a CLL-associated antigen.

  1988cited by this paper
• Lymphocyte dysfunction in cartilage-hair hypoplasia: evidence for an intrinsic defect in cellular proliferation.

  1982cited by this paper

• Recent trends and advances in novel formulations as an armament in Bcl-2/Bax targeted breast cancer.

  2024cites this paper
• Targeting Bcl-2 with Indole Scaffolds: Emerging Drug Design Strategies for Cancer Treatment.

  2024cites this paper
• Comprehensive review of Bcl‐2 family proteins in cancer apoptosis: Therapeutic strategies and promising updates of natural bioactive compounds and small molecules

  2024influential citation
• Dirigent gene editing of gossypol enantiomers for toxicity-depleted cotton seeds

  2023cites this paper
• Cobalt Ferrite-Gossypol Coordination Nanoagents with High Photothermal Conversion Efficiency Sensitizing Chemotherapy against Bcl-2 to Induce Tumor Apoptosis.

  2023cites this paper
• Bacterial endotoxin lipopolysaccharides regulate gene expression in human colon cancer cells

  2023cites this paper
• Gossypol and Its Natural Derivatives: Multitargeted Phytochemicals as Potential Drug Candidates for Oncologic Diseases

  2022cites this paper
• Identification of Bcl2 as a Stably Expressed qPCR Reference Gene for Human Colon Cancer Cells Treated with Cottonseed-Derived Gossypol and Bioactive Extracts and Bacteria-Derived Lipopolysaccharides

  2022cites this paper
• Apogossypolone Inhibits Cell Proliferation and Epithelial-Mesenchymal Transition in Cervical Cancer via Activating DKK3

  2022cites this paper
• Cottonseed extracts regulate gene expression in human colon cancer cells

  2022cites this paper
• Targeting Bcl-2 for cancer therapy.

  2021cites this paper
• Gossypol decreased cell viability and down-regulated the expression of a number of genes in human colon cancer cells

  2021cites this paper
• Apoptosis and Cancer

  2020cites this paper
• Curse or Cure? A Perspective on the Developability of Aldehydes as Active Pharmaceutical Ingredients.

  2020cites this paper
• Metabolic Plasticity in Chemotherapy Resistance

  2020cites this paper
• Herb-Induced Liver Injury: Phylogenetic Relationship, Structure-Toxicity Relationship, and Herb-Ingredient Network Analysis

  2019cites this paper
• Molecular Insights into Potential Contributions of Natural Polyphenols to Lung Cancer Treatment

  2019cites this paper
• The Role of BFl-1 in Cancer Unravels Inhibition Mechanism

  2019cites this paper
• Natural Product Gossypol and Its Derivatives in Precision Cancer Medicine.

  2019cites this paper
• Apogossypol-mediated reorganisation of the endoplasmic reticulum antagonises mitochondrial fission and apoptosis

  2019cites this paper
• The chemical biology of apoptosis: Revisited after 17 years.

  2019cites this paper
• Targeting mitochondria in cancer: current concepts and immunotherapy approaches

  2018cites this paper
• Recombinant MDA-7/IL24 Suppresses Prostate Cancer Bone Metastasis through Downregulation of the Akt/Mcl-1 Pathway

  2018cites this paper
• Sabutoclax, pan-active BCL-2 protein family antagonist, overcomes drug resistance and eliminates cancer stem cells in breast cancer.

  2018cites this paper
• Development and Validation of a Robust QSAR Model for Benzothiazole Hydrazone Derivatives as Bcl-XL Inhibitors

  2018cites this paper
• Mitocans: Mitochondrially Targeted Anti-cancer Drugs

  2018cites this paper
• Cellular and viral oncogenes: the key to unlocking unknowns of Kaposi’s sarcoma-associated herpesvirus pathogenesis

  2018cites this paper
• (±)-Gossypol induces apoptosis and autophagy in head and neck carcinoma cell lines and inhibits the growth of transplanted salivary gland cancer cells in BALB/c mice

  2017cites this paper
• Therapeutics targeting Bcl-2 in hematological malignancies.

  2017cites this paper
• Small molecules targeting Mcl-1: the search for a silver bullet in cancer therapy

  2016cites this paper
• Are BH 3 Domain Peptides Appropriate Surrogates to Study BH 3-Only Protein Function ?

  2016cites this paper
• Identification of a novel BCL2‐specific inhibitor that binds predominantly to the BH1 domain

  2016cites this paper
• Physiological and Pharmacological Control of BAK, BAX, and Beyond.

  2016cites this paper
• Antiapoptotic Bcl-2 protein as a potential target for cancer therapy: A mini review

  2016cites this paper
• Bcl-2 family of proteins as drug targets for cancer chemotherapy: the long way of BH3 mimetics from bench to bedside.

  2015cites this paper
• Pancreatic Cancer Combination Therapy Using a BH3 Mimetic and a Synthetic Tetracycline.

  2015cites this paper
• A Novel Bioavailable BH3 Mimetic Efficiently Inhibits Colon Cancer via Cascade Effects of Mitochondria

  2015cites this paper
• Inhibitory activity of apogossypol in human prostate cancer in vitro and in vivo

  2015cites this paper
• Influence of gossypol acetic acid on the growth of human adenoid cystic carcinoma ACC-M cells and the expression of DNA methyltransferase 1.

  2015cites this paper
• ApoG2 inhibits the antiapoptotic protein, Mcl‑1, and induces mitochondria‑dependent apoptosis in human colorectal cancer cells.

  2015cites this paper
• Apoptosis and Cancer

  2015cites this paper
• Bcl-2 Family: Translational Aspects

  2015cites this paper
• B Cell Lymphoma-2 (BCL-2) Homology Domain 3 (BH3) Mimetics Demonstrate Differential Activities Dependent upon the Functional Repertoire of Pro- and Anti-apoptotic BCL-2 Family Proteins*

  2014cites this paper
• Targeting BCL2-Proteins for the Treatment of Solid Tumours

  2014cites this paper
• Targeting the apoptosis pathway in hematologic malignancies

  2014cites this paper
• Apogossypolone induces autophagy and apoptosis in breast cancer MCF-7 cells in vitro and in vivo

  2014cites this paper
• [Effects of gossypol acetic acid on the proliferation and methylation level of the human MutL homologue 1 gene in human tongue carcinoma cell line Tca8113].

  2014cites this paper
• Novel Therapeutic Strategies for Pancreatic Cancer

  2014cites this paper
• Gossypol's effects on ingestive behaviour in mice: The first step in a systematic process to define gossypol's suitability for use in murine pest management

  2014influential citation
• Cancer therapy: Targeting mitochondria and other sub-cellular organelles.

  2014cites this paper
• Drug Resistance and Molecular Cancer Therapy: Apoptosis Versus Autophagy

  2013cites this paper
• Targeting the apoptosis pathway in prostate cancer.

  2013cites this paper
• ApoG2 induces ER stress-dependent apoptosis in gastric cancer cells in vitro and its real-time evaluation by bioluminescence imaging in vivo.

  2013cites this paper
• Deregulation of BCL 2 family proteins in B-cell lymphomas — molecular , pathogenetic , clinical and therapeutic implications

  2013cites this paper
• Rapid detection assay for the molecular imprinting of gossypol using a two-layer PMAA/SiO2 bulk structure with a piezoelectric imprinting sensor

  2013cites this paper
• Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.

  2013cites this paper
• Bcl-2 antagonists: a proof of concept for CLL therapy

  2013cites this paper
• Heptylprodigiosin induces apoptosis in Jurkat leukemia T cells via CD95 death receptor and evades anti- apoptotic Bcl-2 and Bcl-x L proteins

  2013cites this paper
• BH3 mimetic therapy: an emerging and promising approach to treating chronic lymphocytic leukemia

  2013cites this paper
• Inhibition of human hepatocellular carcinoma HepG2 by phthalocyanine photosensitiser PHOTOCYANINE: ROS production, apoptosis, cell cycle arrest.

  2012cites this paper
• Inhibitors of the anti-apoptotic Bcl-2 proteins: a patent review

  2012cites this paper
• Targeting the anti-apoptotic Bcl-2 family members for the treatment of cancer.

  2012cites this paper
• Sabutoclax, a Mcl-1 antagonist, inhibits tumorigenesis in transgenic mouse and human xenograft models of prostate cancer.

  2012cites this paper
• [BH3 mimetics as a strategy to complement anticancer therapies].

  2012cites this paper
• Selected approaches for rational drug design and high throughput screening to identify anti-cancer molecules.

  2012influential citation
• In silico methods for designing antagonists to anti-apoptotic members of Bcl-2 family proteins.

  2012cites this paper
• Drug repurposing Drug repurposing from an academic perspective

  2012cites this paper
• Structure-based anti-cancer drug development by targeting Bcl-XL

  2012cites this paper
• Pro-apoptotic activity of BH3-only proteins and BH3 mimetics: from theory to potential cancer therapy.

  2012cites this paper
• Mitochondria as Therapeutic Targets for the Treatment of Malignant Disease

  2011cites this paper
• Drug Repurposing from an Academic Perspective.

  2011cites this paper
• The Role of BH3-Only Proteins in Tumor Cell Development, Signaling, and Treatment.

  2011cites this paper
• Epigenetic modulation of human breast cancer by metallofullerenol nanoparticles: in vivo treatment and in vitro analysis.

  2011cites this paper
• An Optically Pure Apogossypolone Derivative as Potent Pan-Active Inhibitor of Anti-Apoptotic Bcl-2 Family Proteins

  2011influential citation
• Apoptosis: from biology to therapeutic targeting

  2011cites this paper
• Targeting Mcl-1 for the therapy of cancer

  2011cites this paper
• Targeting Survival Pathways

  2010cites this paper
• Synthesis and biological evaluation of Apogossypolone derivatives as pan-active inhibitors of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

  2010cites this paper
• Modulation of Apoptosis by Natural Products for Cancer Therapy

  2010cites this paper
• Specificity in the interaction of natural products with their target proteins--a biochemical and structural insight.

  2010cites this paper
• Novel agents for follicular lymphoma.

  2010cites this paper
• CHEMICAL MODIFICATION AND BIOLOGICAL ACTIVITY EXPLORATION OF THE NATURAL PRODUCT-GOSSYPOL

  2010cites this paper
• BI-97C1, an optically pure Apogossypol derivative as pan-active inhibitor of antiapoptotic B-cell lymphoma/leukemia-2 (Bcl-2) family proteins.

  2010cites this paper
• Characterization of the response of melanoma cell lines to inhibition of anti-apoptotic Bcl-2 proteins

  2010cites this paper
• The BH3-Mimetic ABT-737 Induces Mast Cell Apoptosis In Vitro and In Vivo: Potential for Therapeutics

  2010cites this paper
• Targeting survival pathways in lymphoma.

  2010cites this paper
• Mitochondrially targeted anti-cancer agents.

  2010cites this paper
• A novel water-soluble gossypol derivative increases chemotherapeutic sensitivity and promotes growth inhibition in colon cancer.

  2010cites this paper
• Targeting mitochondria for cancer therapy

  2010cites this paper
• Bcl-2 family proteins as therapeutic targets.

  2010cites this paper
• This information is current as Potential for Therapeutics Cell Apoptosis In Vitro and In Vivo : The BH 3-Mimetic ABT-737 Induces

  2010cites this paper
• Exploiting mitochondrial apoptosis for the treatment of cancer.

  2010cites this paper
• Apoptosis in leukemias: regulation and therapeutic targeting.

  2010cites this paper
• Programmed Cell Death Pathways and Current Antitumor Targets

  2009cites this paper
• Apogossypol derivatives as antagonists of antiapoptotic Bcl-2 family proteins

  2009cites this paper
• Engineering a leucine zipper-TRAIL homotrimer with improved cytotoxicity in tumor cells

  2009cites this paper
• Chiral gossypol derivatives: evaluation of their anticancer activity and molecular modeling.

  2009cites this paper
• Gossypol--a polyphenolic compound from cotton plant.

  2009cites this paper
• Molecular targeted therapies for indolent lymphomas: where are we?

  2009cites this paper
• New targets for the treatment of follicular lymphoma

  2009influential citation